SCHEMBL4247133

SCHEMBL4247133

COC(=O)[C@H](Cc1ccc(CCCc2cccc(N(C)c3ccccc3)n2)cc1)NC(=S)c1c(Cl)cccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 15/20 0.49
ITGA5 P08648 14/20 0.49
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
ITGB3 P05106 4/20 0.40
ITGAV P06756 4/20 0.40
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8234189 0.83 ITGB1 (0.68) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4064305 0.83 ITGB1 (0.68) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4927156 0.76 ITGB1 (0.82) ITGB1ITGA5ITGB3ITGAV
SCHEMBL8234267 0.76 ITGB1 (0.82) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4928350 0.74 ITGB1 (0.82) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4074572 0.71 KLK5 (0.44) ITGB1ITGA5ITGB3
SCHEMBL4063291 0.70 ITGB1 (0.64) ITGB1ITGA5ITGB3ITGAV
SCHEMBL5784819 0.69 ITGA4 (0.61) ITGB1ITGA4ITGB7
SCHEMBL4067205 0.69 KLK5 (0.44) ITGB1ITGA5ITGB3
SCHEMBL8228529 0.69 KLK5 (0.44) ITGB1ITGA5ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049490-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS Astra Zeneca AB (SE) 2009-04-22 EP disclosed
WO-2007141473-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS ASTRAZENECA AB (SE) 2007-12-13 WO disclosed